Sign Up to like & get recommendations! 0
Published in 2024 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.52198
Abstract: It is unknown if cognition is impaired before clinical onset of paediatric acquired demyelinating syndromes. We conducted a matched cohort study using prospectively collected educational data in multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Acta neurologica Belgica"
DOI: 10.1007/s13760-021-01703-4
Abstract: To evaluate the clinical and neuroimaging features of pediatric acquired demyelinating syndromes (ADS) in a tertiary pediatric neurology clinic in Turkey. All children diagnosed with any subset of ADS between 2013 and 2018 were included… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "European Journal of Paediatric Neurology"
DOI: 10.1016/j.ejpn.2017.04.961
Abstract: Multiple sclerosis (MS) is a chronic neurological disorder defined by recurrent episodes of central nervous system (CNS) demyelination, ultimately culminating in physical and cognitive disability. While it is rare in the paediatric population, MS in… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Neuropediatrics"
DOI: 10.1055/a-1863-1862
Abstract: This study aimed to determine the seropositivity of myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) and aquaporin-4 antibodies (AQP4-Ab) and outcomes in children with acquired demyelinating syndromes (ADS). Children (6months-15years) with suspected ADS were enrolled and tested… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Current Opinion in Pediatrics"
DOI: 10.1097/mop.0000000000001405
Abstract: Purpose of review To highlight the clinical presentation, diagnostic approach, and management of acquired inflammatory demyelinating syndromes in children. Recent findings The identification of myelin oligodendrocyte glycoprotein antibody-associated disease in 2017 and evolving evidence regarding… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current Opinion in Neurology"
DOI: 10.1097/wco.0000000000000685
Abstract: Purpose of review Research on multiple sclerosis (MS) pathogenesis and therapy is to a large extent driven by results obtained in experimental autoimmune encephalomyelitis (EAE). This approach provided deep insights into the mechanism of brain… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1106472
Abstract: Introduction Concern of a correlation between disease relapse in patients with acquired demyelinating disorders of central nervous system (CNS) and SARS-CoV2 vaccines has been raised. In this single center study, we retrospectively evaluated safety of… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Neurology India"
DOI: 10.4103/0028-3886.273621
Abstract: Distal acquired demyelinating symmetric neuropathy (DADS) is a variant of chronic inflammatory demyelinating polyneuropathy (CIDP) characterized by symmetrical, distal, sensory or sensorimotor involvement. DADS with M-protein (DADS-M) is less responsive to immunotherapy compared to those… read more here.